Does the site of bleeding matter? A stratified analysis on Flocation of TIMI-graded bleedings and their impact on 12-month outcome in patients with ST-segment elevation myocardial infarction

Trans-radial approach for catheterisation in non-ST segment elevation acute coronary syndrome: an analysis of major bleeding complications in the ABOARD Study

(2011) G. Cayla et al.   HEART

Incidence, Prognostic Impact, and Influence of Antithrombotic Therapy on Access and Nonaccess Site Bleeding in Percutaneous Coronary Intervention

(2011) Freek W.A. Verheugt et al.   JACC-Cardiovascular Interventions

Three-year follow-up of the ARTS-II# – sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease

(2011) Patrick Serruys et al.   EuroIntervention

A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes

(2010) Roxana Mehran et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial

(2010) Shamir R Mehta et al.   LANCET

Hematomas of at least 5 cm and outcomes in patients undergoing elective percutaneous coronary intervention: Insights from the SafeTy and Efficacy of Enoxaparin in PCI patients, an internationaL randomized Evaluation (STEEPLE) trial

(2009) Harvey D. White et al.   AMERICAN HEART JOURNAL

Risk profile and benefits from Gp IIb-IIIa inhibitors among patients with ST-segment elevation myocardial infarction treated with primary angioplasty: a meta-regression analysis of randomized trials

(2009) G. De Luca et al.   EUROPEAN HEART JOURNAL

Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention

(2009) E. Marc Jolicœur et al.   EUROPEAN HEART JOURNAL

Gastrointestinal Bleeding in Patients With Acute Coronary Syndromes: Incidence, Predictors, and Clinical Implications

(2009) Eugenia Nikolsky et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial

(2009) Roxana Mehran et al.   LANCET

Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

(2008) Holger Thiele et al.   CIRCULATION

Major Femoral Bleeding Complications After Percutaneous Coronary Intervention

(2008) Brendan J. Doyle et al.   JACC-Cardiovascular Interventions

Comparison of Angioplasty With Infusion of Tirofiban or Abciximab and With Implantation of Sirolimus-Eluting or Uncoated Stents for Acute Myocardial InfarctionThe MULTISTRATEGY Randomized Trial

(2008) Marco Valgimigli   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Prehospital initiation of tirofiban in patients with ST-elevation myocardial infarction undergoing primary angioplasty (On-TIME 2): a multicentre, double-blind, randomised controlled trial

(2008) Arnoud WJ van't Hof et al.   LANCET

2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention

(2007) Spencer B. King et al.   CIRCULATION

2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction

(2007) Elliott M. Antman et al.   CIRCULATION